PON1 as a model for integration of genetic, epigenetic, and expression data on candidate susceptibility genes

Abstract Recent genome- and epigenome-wide studies demonstrate that the DNA methylation is controlled in part by genetics, highlighting the importance of integrating genetic and epigenetic data. To better understand molecular mechanisms affecting gene expression, we used the candidate susceptibility gene paraoxonase 1 (PON1) as a model to assess associations of PON1 genetic polymorphisms with DNA methylation and arylesterase activity, a marker of PON1 expression. PON1 has been associated with susceptibility to obesity, cardiovascular disease, and pesticide exposure. In this study, we assessed DNA methylation in 18 CpG sites located along PON1 shores, shelves, and its CpG island in blood specimens collected from newborns and 9-year-old children participating (n = 449) in the CHAMACOS birth cohort study. The promoter polymorphism, PON1-108, was strongly associated with methylation, particularly for CpG sites located near the CpG island (P << 0.0005). Among newborns, these relationships were even more pronounced after adjusting for blood cell composition. We also observed significant decreases in arylesterase activity with increased methylation at the same nine CpG sites at both ages. Using causal mediation analysis, we found statistically significant indirect effects of methylation (β(95% confidence interval): 6.9(1.5, 12.4)) providing evidence that DNA methylation mediates the relationship between PON1-108 genotype and PON1 expression. Our findings show that integration of genetic, epigenetic, and expression data can shed light on the functional mechanisms involving genetic and epigenetic regulation of candidate susceptibility genes like PON1.

[1]  Alan Hubbard,et al.  Estimation of blood cellular heterogeneity in newborns and children for epigenome‐wide association studies , 2015, Environmental and molecular mutagenesis.

[2]  A. Maxwell,et al.  Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood‐derived DNA from individuals with Type 1 diabetes , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[3]  N. Holland,et al.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health , 2015, Current opinion in pediatrics.

[4]  Michael Q. Zhang,et al.  Integrative analysis of 111 reference human epigenomes , 2015, Nature.

[5]  Yen-Tsung Huang,et al.  Integrative modeling of multi‐platform genomic data under the framework of mediation analysis , 2015, Statistics in medicine.

[6]  D. Schübeler.  Function and information content of DNA methylation , 2015, Nature.

[7]  M. Bonder,et al.  Genetic and epigenetic regulation of gene expression in fetal and adult human livers , 2014, BMC Genomics.

[8]  N. Holland,et al.  Organophosphate pesticide exposure, PON1, and neurodevelopment in school-age children from the CHAMACOS study. , 2014, Environmental research.

[9]  Yen-Tsung Huang,et al.  Integrative modeling of multiple genomic data from different types of genetic association studies. , 2014, Biostatistics.

[10]  Manolis Kellis,et al.  Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci , 2014 .

[11]  Rafael A. Irizarry,et al.  Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..

[12]  J. Martínez,et al.  Arylesterase activity is associated with antioxidant intake and paraoxonase-1 (PON1) gene methylation in metabolic syndrome patients following an energy restricted diet , 2014, EXCLI journal.

[13]  Luigi Ferrucci,et al.  GeMes, clusters of DNA methylation under genetic control, can inform genetic and epigenetic analysis of disease. , 2014, American journal of human genetics.

[14]  Jeremy Chien,et al.  Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer , 2014, BMC Medical Genomics.

[15]  S. Orkin,et al.  Nathan and Oski's hematology of infancy and childhood , 2013 .

[16]  P. Farnham,et al.  Cross-talk between Site-specific Transcription Factors and DNA Methylation States* , 2013, The Journal of Biological Chemistry.

[17]  Anna Decker,et al.  Considerations for normalization of DNA methylation data by Illumina 450K BeadChip assay in population studies , 2013, Epigenetics.

[18]  Stephanie A. Tammen,et al.  Epigenetics: the link between nature and nurture. , 2013, Molecular aspects of medicine.

[19]  S. Juo,et al.  A functional polymorphism of PON1 interferes with microRNA binding to increase the risk of ischemic stroke and carotid atherosclerosis. , 2013, Atherosclerosis.

[20]  R. Emsley,et al.  PARAMED: Stata module to perform causal mediation analysis using parametric regression models , 2013 .

[21]  Linda Valeri,et al.  Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. , 2013, Psychological methods.

[22]  R. Fry,et al.  Arsenic and the Epigenome: Interindividual Differences in Arsenic Metabolism Related to Distinct Patterns of DNA Methylation , 2013, Journal of biochemical and molecular toxicology.

[23]  Martin J. Aryee,et al.  Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in Rheumatoid Arthritis , 2013, Nature Biotechnology.

[24]  Francesco Marabita,et al.  A beta-mixture quantile normalization method for correcting probe design bias in Illumina Infinium 450 k DNA methylation data , 2012, Bioinform..

[25]  Susan K. Murphy,et al.  450K Epigenome-Wide Scan Identifies Differential DNA Methylation in Newborns Related to Maternal Smoking during Pregnancy , 2012, Environmental health perspectives.

[26]  Katherine C Sexton,et al.  Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. , 2012, Biopreservation and biobanking.

[27]  G. Rimbach,et al.  Determinants of paraoxonase 1 status: genes, drugs and nutrition. , 2011, Current medicinal chemistry.

[28]  K. Gunderson,et al.  High density DNA methylation array with single CpG site resolution. , 2011, Genomics.

[29]  Asa Bradman,et al.  Association of Organophosphate Pesticide Exposure and Paraoxonase with Birth Outcome in Mexican-American Women , 2011, PloS one.

[30]  Kevin M. Bowling,et al.  Analysis of DNA Methylation in a Three-Generation Family Reveals Widespread Genetic Influence on Epigenetic Regulation , 2011, PLoS genetics.

[31]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[32]  K. Beckman,et al.  Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican‐American mothers and children , 2011, Environmental and molecular mutagenesis.

[33]  L. Costa,et al.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. , 2011, Biochemical pharmacology.

[34]  Xiao Zhang,et al.  Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis , 2010, BMC Bioinformatics.

[35]  J. Mill,et al.  Allele-specific methylation in the human genome , 2010, Epigenetics.

[36]  N. Holland,et al.  PON1 and Neurodevelopment in Children from the CHAMACOS Study Exposed to Organophosphate Pesticides in Utero , 2010, Environmental health perspectives.

[37]  R. Shoemaker,et al.  Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. , 2010, Genome research.

[38]  C. Infante-Rivard.  Genetic association between single nucleotide polymorphisms in the paraoxonase 1 (PON1) gene and small-for-gestational-age birth in related and unrelated subjects. , 2010, American journal of epidemiology.

[39]  R. Plomin,et al.  Allelic skewing of DNA methylation is widespread across the genome. , 2010, American journal of human genetics.

[40]  Scott M. Williams,et al.  Maternal and Fetal Genetic Associations of PTGER3 and PON1 with Preterm Birth , 2010, PloS one.

[41]  N. Holland,et al.  Validation of PON1 enzyme activity assays for longitudinal studies. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[42]  R. Waterland.  Is Epigenetics an Important Link between Early Life Events and Adult Disease? , 2009, Hormone Research in Paediatrics.

[43]  J. Poirier,et al.  Polymorphisms at the Paraoxonase 1 L55M and Q192R Loci Affect the Pathophysiology of Alzheimer’s Disease: Emphasis on the Cholinergic System and Beta-Amyloid Levels , 2008, Neurodegenerative Diseases.

[44]  P. Connelly,et al.  Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma Published, JLR Papers in Press, September 28, 2007. , 2008, Journal of Lipid Research.

[45]  Tom R. Gaunt,et al.  The association of the paraoxonase (PON1) Q192R polymorphism with depression in older women: findings from the British Women’s Heart and Health Study , 2006, Journal of Epidemiology and Community Health.

[46]  Patrick J Heagerty,et al.  TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease Published, JLR Papers in Press, February 11, 2006. , 2006, Journal of Lipid Research.

[47]  N. Holland,et al.  PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity , 2006, Pharmacogenetics and genomics.

[48]  K. Beckman,et al.  Paraoxonase Polymorphisms, Haplotypes, and Enzyme Activity in Latino Mothers and Newborns , 2006, Environmental health perspectives.

[49]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[50]  Y. Ikeda,et al.  Roles of Sp1 and protein kinase C in regulation of human serum paraoxonase 1 (PON1) gene transcription in HepG2 cells. , 2004, Atherosclerosis.

[51]  De-Pei Liu,et al.  Paraoxonase gene polymorphisms, oxidative stress, and diseases , 2003, Journal of Molecular Medicine.

[52]  K. Irvine,et al.  Glycosylation regulates Notch signalling , 2003, Nature Reviews Molecular Cell Biology.

[53]  S. Deakin,et al.  Paraoxonase-1 promoter haplotypes and serum paraoxonase: a predominant role for polymorphic position - 107, implicating the Sp1 transcription factor. , 2003, The Biochemical journal.

[54]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[55]  T. Egashira,et al.  A sandwich enzyme-linked immunosorbent assay for human serum paraoxonase concentration. , 2000, Journal of lipid research.

[56]  C. Furlong,et al.  Determination of paraoxonase (PON1) status requires more than genotyping. , 1999, Pharmacogenetics.

[57]  J. Lilleyman.  Hematology of Infancy and Childhood , 1993 .

[58]  W. Schaffner,et al.  Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. , 1988, Genes & development.

[59]  Judith G Giri,et al.  2012 best practices for repositories collection, storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. , 2012, Biopreservation and biobanking.

[60]  N. Holland,et al.  CHAMACOS, A Longitudinal Birth Cohort Study: Lessons from the Fields , 2003 .

[61]  B. Houwen.  The Differential Cell Count , 2001 .